Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 1 Neuroimmunology and Neurogenetics /

Brain tumors comprise about 5–9% of all human neoplasms; and interestingly the central nervous system (CNS) neoplasms are ranked among the most prevalent neoplasms of childhood as well. Besides to the morphologic and histopathologic characteristics, and as each pathologic states first starts with mo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor corporatiu: SpringerLink (Online service)
Altres autors: Rezaei, Nima (Editor), Hanaei, Sara (Editor)
Format: Electrònic eBook
Idioma:anglès
Publicat: Cham : Springer International Publishing : Imprint: Springer, 2023.
Edició:1st ed. 2023.
Col·lecció:Advances in Experimental Medicine and Biology, 1394
Matèries:
Accés en línia:https://doi.org/10.1007/978-3-031-14732-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
Taula de continguts:
  • Chaptre 1. Brain and Spinal Cord Tumors Among the Life-Threatening Health Problems: An Introduction
  • Chaptre 2. Epidemiology of Brain and Spinal Cord Tumors
  • Chaptre 3. The Role of Neuro-inflammation and Innate Immunity in Pathophysiology of Brain and Spinal Cord Tumors
  • Chaptre 4. The Role of Cellular Immunity and Adaptive Immunity in Pathophysiology of Brain and Spinal Cord Tumors
  • Chaptre 5. Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors
  • Chaptre 6. Cell of Origin of Brain and Spinal Cord Tumors
  • Chaptre 7. The Role of Bioinformatics and Imaging Models in Tumorigenesis and Treatment Response of Brain and Spinal Cord Neoplasms
  • Chaptre 8. The Role of Epigenetics in Brain and Spinal Cord Tumors
  • Chaptre 9. Stem Cells and Targeted Gene Therapy in Brain and Spinal Cord Tumors
  • Chaptre 10. Nutrition and Diet: A Double-Edged Sword in Development and Treatment of Brain Tumors
  • Chaptre 11. The Role of Nanotechnology in Brain Tumors
  • Chaptre 12.The Role of Nanotechnology in Spinal Cord Tumors
  • Chaptre 13. The Economic Burden of Malignant Brain Tumors.